Laurion Capital Management LP Acadia Pharmaceuticals Inc Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $952,128 - $1.32 Million	-23,200 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $456,233 - $714,039	-12,527 Reduced 35.06%	23,200 $957,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $1.4 Million - $1.88 Million	35,727 New	35,727 $1.73 Million
Q4 2019 Feb 13, 2020	SELL	$36.21 - $51.4 $1.11 Million - $1.57 Million	-30,600 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $679,932 - $1.35 Million	30,600 New	30,600 $1.1 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.